Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014.

Paolo Curatolo,Yuri Bozzi,Lindsay M Oberman,Egidio Dâ€™Angelo,Maria Vincenza Catania,Enrico Cherubini,Yehezkel Ben-Ari,Christian Rosenmund,Lisa Mapelli

doi:10.3389/fncel.2014.00309

Abstract

New progresses into the molecular and cellular mechanisms of autism spectrum disorders (ASDs) have been discussed in 1 day international symposium held in Pavia (Italy) on July 4th, 2014 entitled “synapses as therapeutic targets for autism spectrum disorders” (satellite of the FENS Forum for Neuroscience, Milan, 2014). In particular, world experts in the field have highlighted how animal models of ASDs have greatly advanced our understanding of the molecular pathways involved in synaptic dysfunction leading sometimes to “synaptic clinical trials” in children.

Highlights

Autism comprises a wide range of neuro-developmental disorders known as autism spectrum disorders (ASDs), characterized by deficits in verbal and non-verbal communication, impaired social interactions, restricted interest, and stereotyped behavior
New progresses into the molecular and cellular mechanisms of autism spectrum disorders (ASDs) have been discussed in 1 day international symposium held in Pavia (Italy) on July 4th, 2014 entitled “synapses as therapeutic targets for autism spectrum disorders”
World experts in the field have highlighted how animal models of ASDs have greatly advanced our understanding of the molecular pathways involved in synaptic dysfunction leading sometimes to “synaptic clinical trials” in children

Summary

Introduction

Autism comprises a wide range of neuro-developmental disorders known as autism spectrum disorders (ASDs), characterized by deficits in verbal and non-verbal communication, impaired social interactions, restricted interest, and stereotyped behavior. New progresses into the molecular and cellular mechanisms of autism spectrum disorders (ASDs) have been discussed in 1 day international symposium held in Pavia (Italy) on July 4th, 2014 entitled “synapses as therapeutic targets for autism spectrum disorders” (satellite of the FENS Forum for Neuroscience, Milan, 2014).

Results

Conclusion